Biology and treatment of neuroblastoma (Q41586579)

4 October 2017

1 reference

title

Biology and treatment of neuroblastoma (English)

1 reference

4 October 2017

Castleberry RP

1

1 reference

4 October 2017

1 August 1997

1 reference

Pediatric Clinics of North America

4 October 2017

1 reference

4 October 2017

44

1 reference

4 October 2017

919-937

1 reference

4 October 2017

4

1 reference

Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma

4 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

trk and ret proto-oncogene expression in human neuroblastoma specimens: high frequency of trk expression in non-advanced stages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Molecular basis for heterogeneity in human neuroblastomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Neuroblastoma. Effect of genetic factors on prognosis and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Clinical implications of oncogene activation in human neuroblastomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Prognostic factors in neuroblastomas treated in Denmark from 1943 to 1980. A statistical estimate of prognosis based on 253 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Infants with neuroblastoma and regional lymph node metastases have a favorable outlook after limited postoperative chemotherapy: a Pediatric Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Neuroblastoma: influence of age at diagnosis, stage, tumor site, and sex on prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Special pattern of widespread neuroblastoma with a favourable prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Localized neuroblastoma. Surgical and pathologic staging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Intractable diarrhea in children with VIP-secreting ganglioneuroblastomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Do infants with stage IV-S neuroblastoma need treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

A review of 17 IV-S neuroblastoma patients at the children's hospital of philadelphia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Prognostic factor in neuroblastoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

A proposed staging for children with neuroblastoma.Children's cancer study group A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

CD44--a new prognostic marker for neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Multi-modality megatherapy with [131I]metaiodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: Feasibility study of a new strategy for advanced neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Tumor and urine catecholamines (CATs) in neurogenic tumors. Correlations with other prognostic factors and survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Metastatic neuroblastoma: Factors influencing survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Surgicopathologic staging of neuroblastoma: prognostic significance of regional lymph node metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Congenital neuroblastoma, neuroblastoma in situ, and the normal fetal development of the adrenal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Neuroblastoma: review of the literature and an examination of factors contributing to its enigmatic charcter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Molecular cloning of a human gene that is a member of the nerve growth factor family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the Pediatric Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

False negative bone scans in neuroblastoma metastatic to the ends of long bones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Severe hypertension in a child with ganglioneuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Primary extracranial neuroblastoma with central nervous system metastases characterization by clinicopathologic findings and neuroimaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Ganglioneuroblastoma in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

The trk proto-oncogene encodes a receptor for nerve growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Familial neuroblastoma. Case reports, literature review, and etiologic considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Treatment of adult neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Neurotrophin-3: a neurotrophic factor related to NGF and BDNF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Stage II neuroblastoma. Adverse prognostic significance of lymph node involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Expression of the Gene for Multidrug-Resistance–Associated Protein and Outcome in Patients with Neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Prognostic factors in Neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

The neurobiology of the opsoclonus-myoclonus syndrome

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

inferred from DOI database lookup

7 January 2021

based on heuristic

High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Primary structure and biological activity of a novel human neurotrophic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Influence of the mother's prenatal drug consumption on risk of neuroblastoma in the child

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Neuroblastoma with intracranial involvement: an ENSG Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Serum lactate dehydrogenase in childhood neuroblastoma. A Pediatric Oncology Group recursive partitioning study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

A surgical perspective on the current staging in neuroblastoma--the International Neuroblastoma Staging System proposal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Neuroblastoma and paternal occupation. A case-control analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

The prognostic significance of age and pattern of metastases in stage IV-S neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Serial determination of serum neuron-specific enolase in patients with neuroblastoma and other pediatric tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Neuroblastoma consensus deletion maps to 1p36.1-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Paternal occupational exposure to electromagnetic fields and neuroblastoma in offspring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

A population-based study of the usefulness of screening for neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

Prognostic factors in metastatic neuroblastoma. A multivariate analysis of 182 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Age and prognosis in neuroblastoma. Review of 112 patients younger than 2 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970537-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70537-X

1 reference

4 October 2017

1 reference

PubMed ID

9286292